LDH-L
|
Mast Cell Leukemia
|
LDH-L
|
Mast Cell Leukemia
|
T-lymphocyte cell therapy Sensitive: C3 – Early Trials
|
T-lymphocyte cell therapy Sensitive: C3 – Early Trials
|
LDH-L
|
Diffuse Large B Cell Lymphoma
|
LDH-L
|
Diffuse Large B Cell Lymphoma
|
T-lymphocyte cell therapy Sensitive: C3 – Early Trials
|
T-lymphocyte cell therapy Sensitive: C3 – Early Trials
|
LDH-L
|
Uveal Melanoma
|
LDH-L
|
Uveal Melanoma
|
pembrolizumab + SNDX-275 Sensitive: C3 – Early Trials
|
pembrolizumab + SNDX-275 Sensitive: C3 – Early Trials
|